Albemarle revenue and financials
$104.59Change from previous close: −0.42%Absolute change: −$0.44
In the fiscal year ended December 2025, Albemarle reported revenue of $5.14B (−4.37% year over year). The net loss was $510.63M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −4.37%
- 2025 vs 2024
- Net margin
- -9.9%
- 2024: -21.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5,143 | 5,378 | 9,617 | 7,320 | 3,328 | 3,129 | 3,589 | 3,375 | 3,072 | 2,677 |
| Cost of revenue | 4,474 | 5,315 | 8,431 | 4,246 | 2,330 | 2,134 | 2,332 | 2,158 | 1,966 | 1,707 |
| Gross profit | 669 | 62.5 | 1,186 | 3,075 | 998 | 995 | 1,258 | 1,217 | 1,106 | 970 |
| Selling, general and administrative | 550 | 618 | 910 | 524 | — | — | — | — | — | — |
| Research and development | 51.4 | 86.7 | 85.7 | 72.0 | 54.0 | 59.2 | 58.3 | 70.1 | 84.3 | 80.5 |
| Operating income | -367 | -1,777 | 252 | 2,470 | 798 | 506 | 666 | 912 | 572 | 601 |
| EBIT | -344 | -1,598 | 363 | 2,556 | — | — | — | — | — | — |
| EBITDA | 314 | -1,010 | 793 | 2,857 | — | — | — | — | — | — |
| Interest expense | 208 | 166 | 116 | 123 | — | — | — | — | — | — |
| Pre-tax income | -552 | -1,764 | 247 | 2,433 | — | — | — | — | — | — |
| Income tax | 157 | 87.1 | 430 | 391 | 29.4 | 54.4 | 88.2 | 145 | 432 | 96.3 |
| Net income | -511 | -1,179 | 1,573 | 2,690 | 124 | 376 | 533 | 694 | 54.9 | 644 |
| Net income to common shareholders | -677 | -1,316 | 1,573 | 2,690 | — | — | — | — | — | — |
| Basic EPS | -5.76 | -11.20 | 13.41 | 22.97 | 1.07 | 3.53 | 5.03 | 6.40 | 0.49 | 5.73 |
| Diluted EPS | -5.76 | -11.20 | 13.36 | 22.84 | 1.06 | 3.52 | 5.02 | 6.34 | 0.49 | 5.68 |
| Average shares (basic) | 118 | 118 | 117 | 117 | — | — | — | — | — | — |
| Average shares (diluted) | 118 | 118 | 118 | 118 | 117 | 107 | 106 | 109 | 112 | 113 |